Whole Exome Sequencing Reveals Mutations in Known Retinal Disease Genes in 33 out of 68 Israeli Families with Inherited Retinopathies

Avigail Beryozkin, Elia Shevah, Adva Kimchi, Liliana Mizrahi-Meissonnier, Samer Khateb, Rinki Ratnapriya, Csilla H. Lazar, Anat Blumenfeld, Tamar Ben-Yosef, Yitzhak Hemo, Jacob Pe'Er, Eduard Averbuch, Michal Sagi, Alexis Boleda, Linn Gieser, Abraham Zlotogorski, Tzipora Falik-Zaccai, Ola Alimi-Kasem, Samuel G. Jacobson, Itay ChowersAnand Swaroop, Eyal Banin, Dror Sharon

Research output: Contribution to journalArticlepeer-review

58 Scopus citations


Whole exome sequencing (WES) is a powerful technique for identifying sequence changes in the human genome. The goal of this study was to delineate the genetic defects in patients with inherited retinal diseases (IRDs) using WES. WES was performed on 90 patient DNA samples from 68 families and 226 known genes for IRDs were analyzed. Sanger sequencing was used to validate potential pathogenic variants that were also subjected to segregation analysis in families. Thirty-three causative mutations (19 novel and 14 known) in 25 genes were identified in 33 of the 68 families. The vast majority of mutations (30 out of 33) have not been reported in the Israeli and the Palestinian populations. Nine out of the 33 mutations were detected in additional families from the same ethnic population, suggesting a founder effect. In two families, identified phenotypes were different from the previously reported clinical findings associated with the causative gene. This is the largest genetic analysis of IRDs in the Israeli and Palestinian populations to date. We also demonstrate that WES is a powerful tool for rapid analysis of known disease genes in large patient cohorts.

Original languageEnglish
Article number13187
JournalScientific Reports
StatePublished - 26 Aug 2015
Externally publishedYes

Bibliographical note

Funding Information:
Some of the data were collected by two clinical researchers who passed away during the study: Prof. David Ben-Ezra and Prof. Saul Merin. This study was supported by the Foundation Fighting Blindness USA (BR-GE-0510-0490-HUJ and BR-GE-0214-0639 to DS), Binational US-Israel foundation (BSF-grant number 2011202 to DS and AS), the Yedidut 1 research grant (to EB) and the intramural research program of the National Eye Institute, National Institutes of Health, USA (to AS).


Dive into the research topics of 'Whole Exome Sequencing Reveals Mutations in Known Retinal Disease Genes in 33 out of 68 Israeli Families with Inherited Retinopathies'. Together they form a unique fingerprint.

Cite this